Black Forest Supplements · Nootropic Pouches · research

Nootropic Pouches — Angles & Launch Landscape

v2, Oct 21 2026, on the three-pull census (US-only brands restored; status and run derived from first/last-seen). The candidate angles scored against the Oct 20 census, set against the approved calendar, with the compliance firewall. Numbers and method are in the research dossier; the creatives are in the swipe gallery; the sends live on the launch hub. No campaign copy.

1 · Product at a glance

SKUPer pouchMax/dayTarget price
SKU-001 Energy + Focusciticoline 225 mg · L-theanine 100 mg · theacrine 100 mg · caffeine 75 mg3$24.99 (target)
SKU-002 Caffeine-Free Focusciticoline 250 mg · paraxanthine 200 mg · L-theanine 50 mg1 (proposed)$39.99 (target)

Three flavors each (Mango, Lemon Mint, Peppermint). First run 37,000, two thirds SKU-002. For men who have outgrown energy drinks. No label, no product name yet; the formula is the concept page.

2 · How the market sells it — vs. our play

The census (three pulls, Oct 20–21) read 1,709 nicotine-free pouch ads from 68 brands. The live US field is 430 ads from 23 brands: Neutonic 133, Ultra Pouches 101, NZE 85, Grinds Coffee Pouches 28, NITRO Pouches 23, Focus Lab 12. Two angles carry it, focus (44.9% of live US ads) and it replaced my nicotine (41.2%). 39 of all pouch ads ran 90 days by true run. In the US, by Meta's own targeting data, the market is 762 pouch ads; 209 of them are Neutonic, whose lead angle is focus (298 US ads on that angle). The dose on the label is open (3 live US ads); caffeine-free is contested by exactly one US brand, Ultra Pouches (paraxanthine, 101 live ads, 100 mg against our 200); clean energy is thin (32 live US ads).

Share of LIVE US-relevant pouch ads by candidate angle, % (430 ads, 23 brands) Every milligram on the label 0.7% Caffeine-free focus 3.5% Focus you can feel 44.9% The nicotine audience, without the claim 41.2% Ditch the energy drinks / the 2pm wall 0% Red = whitespace. Live = seen within 8 days of Oct 21; see the dossier for the method.

The lines that persist: . The category already has its villain turn; ours has to be aimed at a practice (hidden doses, the crash) rather than at nicotine, which we are not allowed to promise anything about.

3 · The five candidate angles

AngleAll pouch ads (share)90d+Live US ads · brandsWhy it is on the list · Gate · Use
AEvery milligram on the label34 (2.0%)03 (0.7%) · 2 brandsWhy Of 18 pouches in the concept page's Amazon scan, 1 itemizes every dose. Our two SKUs print every active and its mg. Three live US ads from two brands run anything like it; two UK brands began to in the last 80 days.
Gate Factual; no physiological claim needed. Clear on every surface in 8b.
Use Lead identity for the reveal onward; the product-free builds attack the practice (hidden doses, proprietary blends) without naming a format.
BCaffeine-free focus54 (3.2%)315 (3.5%) · 1 brandsWhy Keyword demand points here (paraxanthine 10.6k, caffeine-free pouches 3.0k, nootropic pouches caffeine free 1.8k, July). Two thirds of the first run is SKU-002. One US rival is already live on it: Ultra Pouches, paraxanthine, 101 live ads, 100 mg per pouch.
Gate Caffeine-free, never stimulant-free. Paraxanthine's standing as a dietary ingredient is a counsel question (A5).
Use The product's own differentiator; it rides inside A at the reveal and becomes the lead SKU story.
CFocus you can feel507 (29.7%)10193 (44.9%) · 11 brandsWhy The category's table-stakes promise and, in the US, one brand's lane: Neutonic runs it at scale. The concept page's own proof is the ~26% 'no felt effect' complaint.
Gate Structure/function territory; gated on 8b.
Use Supporting proof, not the lead; we would be the second voice in Neutonic's lane.
DThe nicotine audience, without the claim602 (35.2%)11177 (41.2%) · 16 brandsWhy Half the live US field (Ultra Pouches, NZE and most of the small brands). The #1 reason buyers stay (~38% of positive reviews, July).
Gate Cessation and replacement are drug claims; Meta allows only approved cessation products; Stripe prohibits harmful claims. NEVER ours.
Use Address the person (men who left nicotine or energy drinks) and quote customers' words with permalinks; never promise anything about nicotine.
EDitch the energy drinks / the 2pm wall142 (8.3%)00 (0%) · 0 brandsWhy Common (12.5% of pouch ads) and short-lived: none of its ads reached 90 days. The calendar's occasion is the first dark Monday after the clocks change.
Gate Never attack caffeine itself; attack the sugar, the can, the crash.
Use An occasion hook for launch week, not the identity.

4 · The launch flow

SlotDateRoleSubject (approved)Product namedWhat it may spend
01Fri Oct 23VALUE 1 / SET THE STAGEWorth reading, {first_name}!nothe nicotine economy: PMI 3.2B ZYN in a quarter (H1), states $21.7B / 3.4% (H8), 12 to 1 marketing (H8), the court's finding in its words (H10), $600B (H9); nicotine works (H6) and withdrawal takes concentration (H7): the trade, stated, never offered to end; no format word, no product, no dose, no price
02Mon Oct 26VALUE 2 / EDUCATIONWorth knowing, {first_name}!nothe trade-off in full: H5 (92% exposure), H6, H7, H4 (FDA: fewer constituents, not safe); the two halves of the day without naming either SKU; the e-book; the clock change Nov 1 as the hook
03Thu Oct 29VALUE 3 / REVEALThis is for you, {first_name}!yesthe product name; the format, said for the first time: a pouch with no nicotine in it; the two SKUs and every dose; the target price, printed as a target until locked; the rival by name (Ultra), no 100-vs-200 line until verified
04Mon Nov 2LAUNCH DAYIt's here, {first_name}!yesthe offer
05Wed Nov 4EXTENDED / MIDSorry, {first_name}!yesthe stated reason for extending
06Fri Nov 6LAST CHANCEIt's coming to an end, {first_name}!yesthe deadline

Audience on every send: BFMD Rest of USA + Approved Launch States + Florida Launch, 11:00 ET. Slots 01 and 02 may not say the product, its name, any dose, any price, or the words pouch / pouches; the format and the category are reserved for slot 03 (Juan, Oct 20).

5 · Recommendation

The problem is the nicotine economy; the answer is the label. Values 1 and 2 open the trade without the format word: the cigarette companies moved the smoker into ZYN, the states are paid for it, nicotine's focus is partly its own withdrawal (dossier §8c, every line a read document). The reveal answers with A, every milligram printed and no nicotine in either pouch, carrying B inside it against a named rival (Ultra: paraxanthine named, dose unprinted), proving with C, addressing D's person without D's claim, and using E as the launch-week occasion. No 'safer than ZYN', no cessation promise.
Two things decide whether this holds. (1) Counsel on whether an oral pouch can be a dietary supplement at all (8b, A1–A2); if not, the label and every "supports" claim change shape before Oct 29. (2) The per-pouch price: at the targets, ours is roughly 2.5× Wip's and 2.4× Ultra Focus's per pouch. "Every mg on the label" has to read as the reason, or it reads as expensive.

6 · Compliance & integrity firewall

#SurfaceRuleStatus
A1Claims & labelingStatutory definition of a dietary supplement requires a product 'intended for ingestion'GATED
A2Claims & labelingFDA's stated position on mucosal deliveryGATED
A3Claims & labelingFDA daily caffeine reference for healthy adultsCLEAR
A4Claims & labelingFDA guidance on highly concentrated caffeineCLEAR
A5Claims & labelingParaxanthine regulatory standingGATED
A6Claims & labelingProposition 65 status of the five activesUNVERIFIED
A7Claims & labelingStructure/function claims territory on the concept pageGATED
B1Ad channelsMeta: tobacco and related productsCLEAR by text, ENFORCEMENT RISK
B2Ad channelsGoogle Ads: tobaccoCLEAR by text
B3Ad channelsTikTok: cigarettes and tobacco productsUNVERIFIED
C1PaymentsWhich processors sit behind Shopify Payments in the USCLEAR
C2PaymentsStripe prohibited and restricted businessesCLEAR by text, CLAIMS RISK
C3PaymentsPayPal Acceptable Use PolicyCLEAR by text
C4Payments / channelShop channel prohibited productsCLEAR
D1Email / SMSKlaviyo Acceptable Use PolicyCLEAR by text, VOCABULARY RISK
D2Email / SMSKlaviyo SMS and MMS prohibited contentCLEAR by text
D3Email / SMSCTIA Messaging Principles and Best PracticesCLEAR
D4Email / SMSSMS verdict for this arcALLOWED WITH RULES, UNTESTED
E1State lawOregon SB 1571, expanded 'tobacco products' definition, effective June 5 2026CLEAR, WATCH
E2State lawNew York A7814, 'oral nicotine pouch' definitionUNVERIFIED
E3State lawTexas: nicotine pouches are taxable 'tobacco products' (Texas Supreme Court)UNVERIFIED

Formula safety from canon: never attack caffeine, sweeteners, glycerin, natural flavor or "synthetic" as a category. Banned or gated phrases: stimulant-free, guaranteed, clinically proven, Cognizin / TeaCrine / enfinity / Zyn, any quit or replacement framing, "no artificial sweeteners" until a label prints it, "dietary supplement" until counsel answers.

7 · References & sources

Built Oct 20 2026 by _research/build_angles.py. Every number is read from a data file; the recommendation is a recommendation and says so.